GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Cash Flow from Discontinued Operations

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Cash Flow from Discontinued Operations : $0.0 Mil (TTM As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Nobel Biocare Holding AG's cash flow from discontinued operations for the six months ended in Dec. 2013 was $0.0 Mil. It means Nobel Biocare Holding AG received $0.0 Mil from the sale of part of business quarterly. Nobel Biocare Holding AG's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2013 was $0.0 Mil.

Nobel Biocare Holding AG Cash Flow from Discontinued Operations Historical Data

The historical data trend for Nobel Biocare Holding AG's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Cash Flow from Discontinued Operations Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nobel Biocare Holding AG Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2013 was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
BSP:FLRY3 TSE:3360 SHSE:603222 TSE:8086 IRTC XTER:GXI SZSE:002382 XSWX:YPSN TSE:7716 STAA AVNS TSE:7730 ASX:ANN GKOS MMSI TSE:3046 SZSE:002294 TSE:7780 ASX:NAN XKLS:7113
Traded in Other Exchanges
N/A
Address
Website
http://www.nobelbiocare.com
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines

From GuruFocus

The new NobelProcera� Zirconia Implant Bridge simplifies the partnership between clinicians and technicians

By PRNewswire PRNewswire • 02-08-2021

Mario Gabelli Comments on Nobel Biocare Holding AG

By Vera Yuan Vera Yuan • 10-28-2014